Evoq Therapeutics

EVOQ Therapeutics is developing immunotherapies aimed at improving the lives of patients with autoimmune diseases.There are over 80 chronic conditions, many of which are debilitating and life-threatening autoimmune diseases. According to the National Institutes of Health, as many as 23.5 million Americans (7% of the population) suffer from autoimmune diseases, and the prevalence is on the rise.Autoimmune diseases occur when the body's central immune tolerance system breaks down and fails. This leads to T-cell and B-cell mediated self-tissue destruction, resulting in numerous devastating diseases, including – Type 1 diabetes, celiac disease, multiple sclerosis, and rheumatoid arthritis.